Tuesday, October 4, 2022


Biotechnology News Magazine

The Worldwide Femtech Industry is Expected to Reach $58.8 Billion by 2027

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

The “Femtech Market Research Report by Type (Products, Services, and Software), Application, End-use, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19″ report has been added to ResearchAndMarkets.com’s offering.

The Global Femtech Market size was estimated at USD 24.99 billion in 2021 and expected to reach USD 28.77 billion in 2022, and is projected to grow at a CAGR 15.34% to reach USD 58.87 billion by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Femtech Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Femtech Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Femtech Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Femtech Market?

4. What is the competitive strategic window for opportunities in the Global Femtech Market?

5. What are the technology trends and regulatory frameworks in the Global Femtech Market?

6. What is the market share of the leading vendors in the Global Femtech Market?

7. What modes and strategic moves are considered suitable for entering the Global Femtech Market?

Market Dynamics


  • Increasing lifestyle and infectious diseases such as reproductive diseases, chronic diseases, and sexually transmitted infections (STIs)
  • Favorable government initiatives for awareness of women’s health
  • Rising investments in R&D to develop digital healthcare for women


  • Lack of awareness of femtech in developing countries


  • Development of software solutions and technologically advanced services in femtech applications
  • Proliferation of new manufacturers and mobile phone apps keeping track of fertility and pregnancy


  • Societal taboos surrounding women’s health issues

Companies Mentioned

  • ALYK, Inc. (LOLA)
  • Athena Feminine Technologies, Inc.
  • Aytu BioPharma, Inc.
  • Bloomlife, Inc.
  • Chiaro Technology Limited ( Elvie)
  • CORA Healthcare Private Limited
  • Flo Health, Inc.
  • GlowTouch, Inc.
  • Grove Collaborative, Inc.
  • HeraMED Ltd.
  • iSono Health, Inc.
  • Minerva Surgical, Inc.
  • NaturalCycles Nordic AB
  • NUVO Inc.
  • Ovuline, Inc.
  • Plackal Techno Systems Private Limited
  • Prelude Fertility, Inc.
  • Sera Prognostics, Inc.
  • Univfy Inc.

For more information about this report visit here.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine